Integrative analysis of epigenetic and transcriptional interrelations identifies histotype-specific biomarkers in early-stage ovarian carcinoma

Table 1 Training and test cohort histotype and platform characteristics

Cohort name	Accession ID	CCC	EC	HGSC	MC	Year of publication	Platform
Training	GSE101109	13	21	45	7	2018	Illumina Hiseq2500 (SCR_016383)
Test	GSE2109	12	28	31	8	2005	Affymetrix Human Genome U133 Plus 2.0 Array
	GSE6008	8	37	39	13	2007	Affymetrix Human Genome U133 A 2.0 Array
	GSE44104	12	11	28	9	2014	Affymetrix Human Genome U133 Plus 2.0 Array
	E-MTAB-1814	17	19	16	15	2014	Agilent SurePrint G3 GE 8 × 60 k (A-GEOD-16083)

CCC Clear cell carcinoma, EC Endometrioid carcinoma, HGSC High-grade serous carcinoma, MC Mucinous carcinoma
The platforms used across cohorts highlight differences in data acquisition methods, which were accounted for in the analyses

ISSN: 1757-2215